27-Mar-2024
No headlines found.
Alector to Participate in Upcoming Healthcare Conferences
Globe Newswire (Wed, 28-Feb 7:00 AM ET)
Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Globe Newswire (Tue, 27-Feb 4:05 PM ET)
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
Globe Newswire (Tue, 20-Feb 4:05 PM ET)
Globe Newswire (Thu, 8-Feb 7:00 AM ET)
Globe Newswire (Wed, 7-Feb 7:00 AM ET)
Alector Announces Closing of Public Offering
Globe Newswire (Fri, 19-Jan 9:20 AM ET)
Alector Announces Pricing of Public Offering of Common Stock
Globe Newswire (Wed, 17-Jan 8:54 AM ET)
Alector Announces Proposed Public Offering of Common Stock
Globe Newswire (Tue, 16-Jan 4:01 PM ET)
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Alector trades on the NASDAQ stock market under the symbol ALEC.
As of March 27, 2024, ALEC stock price climbed to $6.08 with 262,102 million shares trading.
ALEC has a beta of 0.25, meaning it tends to be less sensitive to market movements. ALEC has a correlation of 0.00 to the broad based SPY ETF.
ALEC has a market cap of $577.64 million. This is considered a Small Cap stock.
Last quarter Alector reported $15 million in Revenue and -$.49 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.28.
In the last 3 years, ALEC stock traded as high as $43.32 and as low as $3.66.
The top ETF exchange traded funds that ALEC belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.
ALEC has underperformed the market in the last year with a price return of -3.6% while the SPY ETF gained +33.6%. ALEC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.5% and -2.1%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
ALEC support price is $5.71 and resistance is $6.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALEC stock will trade within this expected range on the day.